Transrectal Ultrasound (TRUS) in Finding Tumors During Robotic-Assisted Laparoscopic Surgery
Mechanically-Manipulated Transrectal Ultrasound (TRUS) During Robotic-Assisted Laparoscopic Prostatectomy (RALP)
2 other identifiers
interventional
11
1 country
1
Brief Summary
This pilot clinical trial studies mechanically-manipulated ultrasound in finding tumors during robotic-assisted surgery in patients with prostate cancer. Diagnostic procedures, such as ultrasound, may help find prostate cancer and find out how far the disease has spread during surgery
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable prostate-cancer
Started Oct 2011
Shorter than P25 for not_applicable prostate-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2011
CompletedFirst Submitted
Initial submission to the registry
November 29, 2011
CompletedFirst Posted
Study publicly available on registry
December 19, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2012
CompletedJanuary 29, 2014
January 1, 2014
1.2 years
November 29, 2011
January 27, 2014
Conditions
Outcome Measures
Primary Outcomes (1)
Number of patients who have negative margins when a TRUS probe is used during RALP procedure without introducing additional complications.
7 days post-RALP
Study Arms (1)
Diagnostic (TRUS)
EXPERIMENTALPatients undergo TRUS during RALP.
Interventions
Undergo transrectal ultrasound
Undergo robotic-assisted laparoscopic prostatectomy
Eligibility Criteria
You may qualify if:
- Undergoing Robotic Assisted Laparoscopic Prostatectomy
You may not qualify if:
- Known or discovered rectal pathology
- Bleeding hemorrhoids
- Rectal stenosis
- Any prior rectal surgeries
- Prior rectal radiation
- Any known rectal disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Southern Californialead
- National Cancer Institute (NCI)collaborator
Study Sites (1)
USC/Norris Comprehensive Cancer Center
Los Angeles, California, 90033, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Osamu Ukimura
University of Southern California
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 29, 2011
First Posted
December 19, 2011
Study Start
October 1, 2011
Primary Completion
December 1, 2012
Study Completion
December 1, 2012
Last Updated
January 29, 2014
Record last verified: 2014-01